Cargando…
The Downstream Impacts of High Drug Costs for PrEP Have Hindered the Promise of HIV Prevention
Prior to the recent introduction of generic TDF/FTC in the U.S., access to pre-exposure prophylaxis (PrEP) for HIV was greatly limited due to the downstream effects of the high cost of the medication. This article argues that despite drug copay cards and patient assistance programs, the promise of d...
Autor principal: | Farrow, Kenyon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341201/ https://www.ncbi.nlm.nih.gov/pubmed/35902087 http://dx.doi.org/10.1017/jme.2022.35 |
Ejemplares similares
-
The importance of PrEP persistence in preventing HIV infections on PrEP
por: Spinelli, Matthew A, et al.
Publicado: (2020) -
Global implementation of PrEP for HIV prevention: setting expectations for impact
por: Pyra, Maria N, et al.
Publicado: (2019) -
Preparing for long‐acting PrEP delivery: building on lessons from oral PrEP
por: Celum, Connie, et al.
Publicado: (2023) -
Navigating the Intersection of PrEP and Medicaid
por: Seiler, Naomi, et al.
Publicado: (2022) -
Commentary: the value of PrEP for people who inject drugs
por: Coleman, Rosalind L, et al.
Publicado: (2016)